BTK and B-cell chronic lymphocytic leukemia: Besides NOTCH1, several other signaling pathways and molecules, including the B-cell receptor (BCR)-associated kinases, Bruton tyrosine kinase (BTK) and PI3K, and the antiapoptotic protein BCL-2, are altered in CLL contributing to disease pathogenesis and representing new therapeutic targets.